NCT05050032

Brief Summary

The aim of the study was to evaluate the relationship between superior vena cava (SVC) flow measurements within the first 24 hours of life and development of intraventricular hemorrhage in preterm born infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

June 15, 2022

Status Verified

June 1, 2022

Enrollment Period

1.4 years

First QC Date

September 10, 2021

Last Update Submit

June 13, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Superior vena cava (SVC) flow

    This was measured using echocardiography. SVC diameter will be visualized from a high parasternal long axis view. The maximum and minimum internal diameters will be then measured off-line from a frozen two-dimensional image showing the vessel walls at the point where SVC starts to open up into the right atrium. Mean of the maximum and minimum diameter used for the flow calculation. * SVC flow velocity will be visualized from a low subcostal view and the pulsed Doppler recording will be made at the junction of the SVC and the right atrium. Velocity time integral (VTI) will be calculated from the Doppler velocity tracings and averaged over 5 consecutive cardiac cycles. * SVC flow will be calculated using the method described by Kluckow and Evans: SVC flow (ml/kg/min) = {VTI (cm/beat) × 3.14 × (mean SVC diameter2/4) × heart rate (beat/min) }/body weight in kg

    Day 1

  • Intraventricular hemorrhage (IVH) assessment

    Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * Cranial ultrasound will be done and any IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension

    Day 1

  • Intraventricular hemorrhage (IVH) assessment

    Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension

    Day 3

  • Intraventricular hemorrhage (IVH) assessment

    Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * Cranial ultrasound will be done and any IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension

    Day 7

  • Anterior cerebral artery (ACA) flow velocity assessment

    Transcranial Doppler (TCD) ultrasonography was used to assess the anterior cerebral artery flow velocity

    Day 1

Eligibility Criteria

Age1 Day - 1 Day
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Newborns with very low birth weight (≤1500 g) or ≤ 32 weeks gestation who were admitted to neonatal intensive care unit in the first day of life where evaluation of the relationship between superior vena cava (SVC) flow measurements within the first 24 hours of life and development of intraventricular hemorrhage were assessed.

You may qualify if:

  • Newborns with very low birth weight (≤1500 g) or ≤ 32 weeks gestation who were admitted to neonatal intensive care unit in the first day of life.

You may not qualify if:

  • Newborns (more than 32 weeks of gestation
  • Newborns with birth weight more than 1500 g.
  • Newborns with congenital heart diseases excluding (patent ductus arteriosus and patent foramen ovale)
  • Newborns with major congenital malformations.
  • Newborns with birth trauma especially basal skull/temporal bone fractures that require hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Alexandria, 21131, Egypt

Location

Related Publications (3)

  • Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F182-7. doi: 10.1136/fn.82.3.f182.

    PMID: 10794783BACKGROUND
  • Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529-34. doi: 10.1016/s0022-3476(78)80282-0.

    PMID: 305471BACKGROUND
  • Farag MM, Gouda MH, Almohsen AMA, Khalifa MA. Intraventricular hemorrhage prediction in premature neonates in the era of hemodynamics monitoring: a prospective cohort study. Eur J Pediatr. 2022 Dec;181(12):4067-4077. doi: 10.1007/s00431-022-04630-5. Epub 2022 Sep 28.

Study Officials

  • Mohamed AM Khalifa, MBBCh

    Faculty of Medicine, Alexandria University, Egypt

    PRINCIPAL INVESTIGATOR
  • Mohamed H Gouda, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR
  • Ali M Abd Almohsen, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR
  • Marwa M Farag, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer in Pediatrics, Faculty of Medicine

Study Record Dates

First Submitted

September 10, 2021

First Posted

September 20, 2021

Study Start

May 10, 2020

Primary Completion

September 20, 2021

Study Completion

October 1, 2021

Last Updated

June 15, 2022

Record last verified: 2022-06

Locations